Abstract
Pulmonary actinomycosis is a rare and uncommon invasive bacterial disease. We are presenting a case report of 45 year old male patient with severe acute pneumonia with pleural effusion, presenting with fever, fatigue, productive cough, chest pain, dyspnea and swelling on both legs. Microbiological findings showed an isolation of anaerobic bacterium Actinomyces odontolyticus. The antibiogram showed sensitivity on penicillin and penicillin preparations, cephalosporins and carbapenems. There was an intermediate sensitivity on quinolones and there was a resistance on lincosamins and aminoglycosides. Our patient was treated with operation and received appropriate antibiotic therapy, after which there was a very good improvement, both clinically and on control native lung RTGs. This disease has excellent prognosis with early detection and proper treatment. Penicillin is the drug of choice for treatment of pulmonary actinomycosis.
Highlights
Actinomycosis is a rare and uncommon invasive bacterial disease that has been recognized for over a century
Schaedler agar was first read after incubation of 48 hours there were tiny colonies who were colored as Gram positive. These colonies were processed on automated system VITEK 2 with adequate card for anaerobic bacteria (BioMerieux, France) and were identified as Actinomyces odontolyticus, which was very important for setting up a precise diagnosis and proper and adequate treatment of our patient
Pulmonary actinomycosis is a bacterial lung infection caused by actinomycosis
Summary
Snezana Ivic-Kolevska[1], Andreja Arsovski 1 1 Private Health Institution “Re-Medika”, Skopje, Republic of North Macedoniaa. Received: 20-Nov-2020; Revised: 15-Jan-2021; Accepted: 25-Fev-2021; Published: 10-Mar-2021
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
